Watch for Insurance Flags or Rejects for Specialty Meds

You'll have more opportunities to help patients with specialty meds...Repatha (evolocumab), Harvoni (ledipasvir/sofosbuvir), etc.

Specialty meds account for about half of new drugs approved in 2015...and these meds will make up over half of drug spending by 2017.

Be familiar with the basics of specialty meds.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote